Opioid use decreases in US states that legalize medical marijuana – study

Screen Shot 2016-09-20 at 8.45.06 AM.png

From RT

New research shows a decline in the use of opioid painkillers in US states that allow people to treat pain with medical marijuana, affirming the fears of Big Pharma who have been vigorously seeking to frustrate efforts to legalize the herb.

Columbia University researchers examined data from 1999 to 2013 and found an association between a state legalizing medical marijuana and a reduction in testing positive for opioids after dying in a car accident, particularly among drivers aged 21 to 40.

The study, published in the American Journal of Public Health, examined data of 69000 traffic fatalities in 18 states and analyzed the cases in which the presence of opioids was detected.

They found that drivers in that age bracket who died in car crashes, after a medical marijuana law had been implemented, were half as likely to test positive for opioids when compared to similarly aged drivers who crashed in states before such laws were in place.

“That’s a pretty moderate-to-large reduction,” said lead author June H. Kim, a doctoral student in the Department of Epidemiology at Columbia’s Mailman School of Public Health, according to Live Science.

“We would expect the adverse consequences of opioid use to decrease over time in states where medical marijuana use is legal, as individuals substitute marijuana for opioids in the treatment of severe or chronic pain,” Kim said.

This logic is not applicable to those over 40, however, with researchers finding no decrease in opioid use for over 40s in the states with operational medical marijuana programs.

This is consistent with previous research which has found that most medical marijuana patients are aged under 45.

The study comes only days after it emerged that as the amount of prescription painkillers and heroin dependence-related claims have increased, the private healthcare sector has been struggling to deal with the associated costs.

Research from Fair Health found that in 2015, “private payors’ average costs for a patient diagnosed with opioid abuse or dependence were more than 550 percent higher – almost $16,000 more per patient – than the per-patient average cost based on all patients’ claims.”

The report also coincides with the revelation that Insys Therapeutics, which profits off of a painkiller 50 times more potent than heroin, has been funding an anti-legalization campaign in Arizona in an apparent bid to eliminate ‘the competition.’

Insys isn’t the first pharmaceutical company to be found bankrolling anti-marijuana legislation though with a number of alcohol and pharmaceutical companies “heavily” invested in such laws in a number of states, according to The Intercept.

Jill Stein “Marijuana Is Dangerous Because It’s Illegal!” (53:15)

Feds Say Marijuana Isn’t Medicine While Holding Patent on It as Medicine

See: US Government’s medical marijuana patent

Bernie Sanders Slams DEA’s Refusal to Reclassify Marijuana

Marijuana Legalization Fails Again in the United States

Published on Aug 14, 2016

Marijuana advocates who hoped the cascade of states moving to legalize medical marijuana would soften the federal stance on the drug faced disappointment Thursday as the Drug Enforcement Administration announced it will keep marijuana illegal for any purpose.

Marijuana will remain a Schedule 1 substance under the Controlled Substances Act. Substances in Schedule 1 are determined by the Food and Drug Administration to have no medical use. States that allow marijuana for medical use or legalize recreational use remain in defiance of federal law.

The announcement to be published Friday in the Federal Register relaxes the rules for marijuana research to make it easier for institutions to grow marijuana for scientific study. The DEA currently authorizes just one grow facility in Mississippi.

In reaching its conclusion, the DEA said a Health and Human Services evaluation shows marijuana has no ‘‘currently accepted medical use’’ because “the drug’s chemistry is not known and reproducible; there are no adequate safety studies; there are no adequate and well-controlled studies proving efficacy; the drug is not accepted by qualified experts; and the scientific evidence is not widely available.”

Tim Black reports for Coffee with Tim Black.

Progressive News with Tim Black‘ is truly independent media show covering news, politics, and entertainment!

Tim Black gives you ‘News for people who can’t stand the news’, yet want the truth Mainstream Media News Channels won’t tell you.

‘Progressive News with Tim Black’ streams live show noon est. Mon – Fri “Progressive Day Show” and the Live Call In Show “Tim black At Night” streams live 9PM est. Mon – Fri.

►Live Call In Number Here: 323-870-4064
►Stream Shows Here: http://www.youtube.com/c/TimsTake/live

250+ Evidence-Based Health Benefits of Cannabis

WikiLeaks Proves the Alcohol Industry Is Working Against Marijuana

merryjane.com

Screen Shot 2016-08-06 at 10.54.02 PM.png

Written on August 02, 2016 by

Mike Adams

It’s no secret that the alcohol industry is one of the sleaziest opponents to the legalization of marijuana, but the latest WikiLeaks exposure of the Democratic National Committee’s email transmissions, which showed the party’s conspiracy to prevent Senator Bernie Sanders from becoming the Democratic presidential nominee, also revealed that Big Booze is scratching the backs of Congress in an effort to apply pressure to the issue of stoned driving.

A recent dig into the DNC’s leaked emails by Tom Angell, chairman of the national cannabis reform organization Marijuana Majority, discovered that the alcohol industry has been pouring marketing dollars into a campaign aimed at getting federal lawmakers to support legislation designed to combat drugged driving.

The scheme was revealed in a May 2016 issue of POLITICO Huddle, a newsletter for industry insiders, where a paid advertisement from the folks at Wine & Spirits Wholesalers of America, a national trade organization charged with protecting the interests of the wine and spirits industry, shows the organization is extremely interested in persuading Congress to put a leash on legal marijuana. Continue reading